Eduardo Azziz-Baumgartner CDD Headshot

Eduardo Azziz-Baumgartner

Chief, Global Influenza Branch, US Centers for Disease Control and Prevention

Eduardo Azziz-Baumgartner, MD, MPH, serves as the chief for the Global Influenza Branch in CDC’s Influenza Division. He is a subject matter expert in influenza and works closely with ministries of health, the World Health Organization, Task Force for Global Health, and other partners to inform vaccine policies. Dr. Azziz-Baumgartner was previously the team lead for the International Epidemiology and Research Team in the Epidemiology and Prevention Branch from 2015 to 2022 and during this time, he co-led the CDC COVID-19 Response Epidemiology Task Force. From 2007 to 2010, Dr. Azziz-Baumgartner was the head of the Influenza Program in Latin America, and from 2008 to 2010, he was posted to the International Centre for Diarrhoeal Disease Research in Bangladesh.

Dr. Azziz-Baumgartner received his Doctor of Medicine degree from the University of Alabama at Birmingham in 1997, and he completed his residency in family practice at the University of Texas in 2000. In 2003, he earned his Master of Public Health degree at Harvard University Medical School, and he also completed a fellowship in minority health policy . In 2005, Dr. Azziz-Baumgartner completed an Epidemic Intelligence Service (EIS) fellowship at CDC. He has won several awards, including the Arnold Monto Award for Excellence in Epidemiology in 2022, the Charles C. Shepard Award for Excellence in Science in 2018, and the Alexander D. Langmuir Prize for most outstanding manuscript covering an epidemiologic investigation in 2006. Dr. Azziz-Baumgartner has authored and co-authored over 180 publications. He currently serves as the Spanish language media spokesperson for the Influenza Division and mentors mid-career scientists at multiple institutions.

WATCH OUR NEW VIDEO

PIVI – Making the World Safer, Through the Lens of Cote d’Ivoire

PIVI champions global respiratory vaccination programs, forging partnerships and advocating for equitable access to influenza vaccines to mitigate disease burdens, enhance pandemic preparedness, and safeguard communities worldwide.